There’s certainly very good news for the humanity as prevention drug has
been emerged for one of the most deadly disease, HIV or AIDS – a monster eating
thousands of lives every year around the globe.
 |
| Gilead Sciences' Truvada: Promises to prevent HIV/AIDS infection |
According to details; the advisory team of the Food and Drug Administration
(FDA) has endorsed on Thursday the first drug, named as Truvada, shown to prevent HIV infection – the virus responsible of
causing AIDS. Although FDA is not bound to follow the advisory team’s decision,
but in normal circumstances it does. FDA’s final decision is expected in the
mid of next month.
The FDA advisory team recommended approval of the daily pill Truvada for
healthy people who are at high risk of contracting HIV, including gay and
bisexual men and heterosexual couples with one HIV-positive partner.
Even though the Truvada got an important endorsement; but the FDA team has
some reservations about the drug, like:
·
Whether Truvada might lead to the reduced use of
condoms, the most dependable protection against HIV,
·
The effectiveness of Truvada in women, who have
shown much lower rates of protection in studies.
Truvada first came in spotlight three years ago, back in 2010, when government
researchers proved that the drug could stop people from contracting HIV.
The researches kept on studying the effect of the drug and after three years
they reached the points where they conclude that daily doses decrease the risk
of infection in healthy gay and bisexual men by 42%, when accompanied by
condoms and counseling.
Last year another study was conducted which fetched even better results concluding that
Truvada reduced infection by 75% in heterosexual couples in which one partner
was infected with HIV and the other was not.
Report Tags: HIV, AIDS, HIV Infection, Truvada, Gilead Sciences,
FDA, Food and Drug Administration, USA, Health, AIDS Drug, AIDS prevention,
SOURCE:
http://www.latimes.com/health/la-na-fda-
No comments:
Post a Comment